4//SEC Filing
Banyai William 4
Accession 0001214659-23-014607
CIK 0001581280other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:15 PM ET
Size
8.8 KB
Accession
0001214659-23-014607
Insider Transaction Report
Form 4
Banyai William
DirectorChief Operating Officer
Transactions
- Tax Payment
Common Stock
2023-11-02$17.31/sh−2,731$47,274→ 309,599 total - Award
Common Stock
2023-11-02+19,743→ 312,330 total - Award
Common Stock
2023-11-02+41,455→ 351,054 total
Footnotes (3)
- [F1]Represents performance stock units for which target criteria was determined to have been met on November 2, 2023. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2024, subject to continued service or acceleration of vesting as provided in the award agreement.
- [F2]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
- [F3]Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 2, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001753670
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:15 PM ET
- Size
- 8.8 KB